Insights & news

Van Bael & Bellis authors Belgium chapter of Private Antitrust Litigation Global Guide

  • 27/09/2016
  • Articles

Thompson Reuters Practical Law have published their Private Antitrust Litigation Global Guide which features a chapter on Belgium authored by Van Bael & Bellis partners Peter L’Ecluse and Martin Favart and associate Lucas Vanassche. The Guide provides an overview of various aspects of private antitrust litigation and aims to be a first point of reference for those considering the merits of commencing, defending or settling antitrust claims. 

The Belgium chapter can be accessed here.

Key contacts

Related practice areas

Related insights

Sign up for updates
    • 09/07/2020
    • Articles

    Court of Justice of European Union Is Asked Preliminary Questions on Application of Falsified Medicines

    Attached is a note discussing a German reference for a preliminary ruling seeking clarification from the Court of Justice of the European Union regarding the application of the Falsified Medicines Directive to parallel-traded medicines. A judgment is due in 2021.

    Read more
    • 07/07/2020
    • Articles

    European Commission Reviews First Two Years of GDPR: A Success Story with Room for Improvement

    On 24 June 2020, the European Commission has published its first report on the General Data Protection Regulation (the GDPR) which has applied in the EU since May 2018. Overall, the Commission considers the GDPR to be a success story, but, at the same time, it identifies certain areas where there is room for improvement and the challenges that lie ahead. In particular, the Commission notes that the efficient and coordinated enforcement of the GDPR among all Member States is of paramount importance. Moreover, the application of the GDPR to new technologies, such as artificial intelligence and blockchain, requires continuous monitoring. According to the Commission, the Covid-19 crisis has proved that the use of new technologies and data protection go hand in hand. Please click below for a note summarising the Commission’s report.

    Read more
    • 07/07/2020
    • Articles

    European Medicines Agencies Network Strategy to 2025

    The European Medicines Agency (EMA) and the national competent authorities (NCAs) of the 27 EU Member States in addition to those of Iceland, Liechtenstein and Norway presented on 6 July 2020 a proposed network strategy for tackling healthcare challenges in a rapidly evolving environment (see, attachment). The strategy is supposed to apply until 2025 and stakeholders are invited to submit their comments in response to an online questionnaire by 4 September 2020.

    Read more

Subscribe to our updates

Please select the practice areas you are interested in: *